Use Determinants of Smoking Cessation App

August 9, 2022 updated by: Luz BUSTAMANTE, Paris Nanterre University

Determinants of Use of Mobile Apps for Smoking Cessation

The development of mobile applications ("mobile apps") is steadily increasing and appears to be a promising treatment method to help people change unwanted behaviors or maintain a regular relationship with the medical system. Mobile apps aimed at smoking cessation have been shown to be effective. However, if a treatment is not used regularly, it will not have the desired effect. The main objective of this study is to identify what makes a person decide to use a smoking cessation app and to do so regularly. The second objective is to determine what is necessary to achieve long-term change with a mobile app.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Despite the significant decrease in tobacco consumption in France (30% in 2000 vs. 25.4% in 2018), the prevalence of smokers aged 18 to 75 years is still a public issue. Among the new solutions proposed, mobile applications ("mobile apps") seem to be a promising treatment modality. Several advantages to their use are recognized for patients, health professionals and the health system itself. Mobile applications allow accessibility to care and information, the possibility of transposing several proven effective therapeutic principles, the possibility of integrating certain forms of information transmission such as messaging, behavioural feedback and audiovisual media.

Although mobile app development is a growing market, knowledge about the determinants of intention to use this type of technology is very limited, especially for smoking cessation apps. The investigators propose a theoretical model to examine what determines the regular use of mobile apps for smoking cessation among those who want to quit. The investigators use the TAMII model and the operational variables used in a more general study on e-health applications. A chronological organisation based on a three-part behavioural model (antecedent, target behaviour and outcome) is added to the TAMII model. The main objective is to identify the factors of Mobila App Sustain Use (MASU). All definitions of TAM-II will be used : perceived usefulness (PU), perceived ease of use (PEOU) and social norm (SN), as well as the definitions proposed by Choi et al (2014) on the predictors of PU, PEOU and SN.

Study Type

Interventional

Enrollment (Actual)

255

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Nanterre
      • Paris La Defense, Nanterre, France, 92001
        • Universite Paris Nanterre, Epscp

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Participants must meet four inclusion criteria for the study:

Inclusion criteria

  • Age: Be 18 years of age or older,
  • Smoking Status: consider themselves an active smoker
  • Motivation to quit: be willing to quit smoking, in the short and medium term.
  • Agreement to participate: They must also agree to participate in the study. They will have read the information note where the procedure is described; the researchers presented and their rights to withdraw from the study are recalled.

Exclusion criteria:

  • Participants must have a smartphone with an iOS or Android operating system
  • Access to the internet to complete the questionnaires
  • Download the application and receive the updates it offers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: mobile app users
Device: Kwit SAS - smoking cessation app
Kwit is a mobile app for smoking cessation. Different CBT techniques are used by the app already been proved as effective : Case analysis craving tool, Achievements badges,Diary, Goal (outcome) setting, A 9-steps preparation program, psychological education, Emotional monitoring, Access to groups on social networks, different strategies ( NRT/water/meditation), Motivational cards.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First Use
Time Frame: Day 1 - First use
The ratio of people accessing the app after giving them access to it.
Day 1 - First use
Mobile App Sustain Use (MASU)
Time Frame: 90 days post firs use of the mobile apps
The ratio of times the application is accessed per week..
90 days post firs use of the mobile apps
Mobile App Intention Use (MAIU):
Time Frame: Day 15

Questionaire : please specify by selecting a number from 1 to 3, with 1 being "Just once", 2 being "Daily" and 3 being "Several times a day", how often you expect to use this application in the course of :

  1. In the next week
  2. In the next month
Day 15
Mobile App Intention Use (MAIU):
Time Frame: Day 30

Questionaire : please specify by selecting a number from 1 to 3, with 1 being "Just once", 2 being "Daily" and 3 being "Several times a day", how often you expect to use this application in the course of :

  1. In the next week
  2. In the next month
Day 30
Mobile App Intention Use (MAIU):
Time Frame: Day 60

Questionaire : please specify by selecting a number from 1 to 3, with 1 being "Just once", 2 being "Daily" and 3 being "Several times a day", how often you expect to use this application in the course of :

  1. In the next 15 days
  2. In the next month
Day 60
Mobile App Intention Use (MAIU):
Time Frame: Day 90

Questionaire : Please specify by selecting a number from 1 to 3, with 1 being "Just once", 2 being "Daily" and 3 being "Several times a day", how often you expect to use this application in the course of :

  1. In the next week
  2. In the next month
Day 90
Mobile App Satisfaction assessment (MAS):
Time Frame: Day 15
The Mobile App Ratting Scale (MARS) scale is a multidimensional metric that ranks and assesses the quality of mobile apps. The MARS total score can be used to evaluate and compare the quality of an application with others. The total score is calculated as the average of its five categories: user engagement, functionality, aesthetics, information and subjective quality. Each category is rated on a five-point scale ranging from inadequate-1 to excellent-5 (25).This scale has been used previously to assess the quality of smoking cessation apps in the Australian market with high inter-rater reliability (ICC =0.807)
Day 15
Mobile App Satisfaction assessment (MAS):
Time Frame: Day 30
The Mobile App Ratting Scale (MARS) scale is a multidimensional metric that ranks and assesses the quality of mobile apps. The MARS total score can be used to evaluate and compare the quality of an application with others. The total score is calculated as the average of its five categories: user engagement, functionality, aesthetics, information and subjective quality. Each category is rated on a five-point scale ranging from inadequate-1 to excellent-5 (25).This scale has been used previously to assess the quality of smoking cessation apps in the Australian market with high inter-rater reliability (ICC =0.807)
Day 30
Mobile App Satisfaction assessment (MAS):
Time Frame: Day 60
The Mobile App Ratting Scale (MARS) scale is a multidimensional metric that ranks and assesses the quality of mobile apps. The MARS total score can be used to evaluate and compare the quality of an application with others. The total score is calculated as the average of its five categories: user engagement, functionality, aesthetics, information and subjective quality. Each category is rated on a five-point scale ranging from inadequate-1 to excellent-5 (25).This scale has been used previously to assess the quality of smoking cessation apps in the Australian market with high inter-rater reliability (ICC =0.807)
Day 60
Mobile App Satisfaction assessment (MAS):
Time Frame: Day 90
The Mobile App Ratting Scale (MARS) scale is a multidimensional metric that ranks and assesses the quality of mobile apps. The MARS total score can be used to evaluate and compare the quality of an application with others. The total score is calculated as the average of its five categories: user engagement, functionality, aesthetics, information and subjective quality. Each category is rated on a five-point scale ranging from inadequate-1 to excellent-5.This scale has been used previously to assess the quality of smoking cessation apps in the Australian market with high inter-rater reliability (ICC =0.807).
Day 90

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking profile (SP)
Time Frame: 1 day before the first use of the mobile app
The degree of dependence is assessed by the Fagerström Test, which is widely used.
1 day before the first use of the mobile app
Craving intensity (CI)
Time Frame: 1 day before before the first use of the mobile app
The visual analog scale or VAS was used to measure the average craving intensity .
1 day before before the first use of the mobile app
Craving intensity (CI)
Time Frame: Day 15
The visual analog scale or VAS was used to measure the average craving intensity .
Day 15
Craving intensity (CI)
Time Frame: Day 30
The visual analog scale or VAS was used to measure the average craving intensity .
Day 30
Craving intensity (CI)
Time Frame: Day 60
The visual analog scale or VAS was used to measure the average craving intensity .
Day 60
Craving intensity (CI)
Time Frame: Day 90
The visual analog scale or VAS was used to measure the average craving intensity .
Day 90
Behavior change : Smoking cessation
Time Frame: Day 15
Self-reported 15-day point prevalence smoking status. Since your first use of the app have you smoked a cigarette (even a puff)?
Day 15
Behavior change : Smoking cessation
Time Frame: Day 30
Self-reported 30-day point prevalence smoking status. Since your first use of the app have you smoked a cigarette (even a puff)?
Day 30
Behavior change : Smoking cessation
Time Frame: Day 60
Self-reported 60-day point prevalence smoking status. Since your first use of the app have you smoked a cigarette (even a puff)?
Day 60
Behavior change : Smoking cessation
Time Frame: Day 90
Self-reported 90-day point prevalence smoking status. Since your first use of the app have you smoked a cigarette (even a puff)?
Day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Paris Nanterre University

Investigators

  • Principal Investigator: Lucia ROMO, Pr. de psychologie clinique UNIVERSITE PARIS NANTERRE

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2022

Primary Completion (Actual)

June 21, 2022

Study Completion (Actual)

August 8, 2022

Study Registration Dates

First Submitted

March 9, 2022

First Submitted That Met QC Criteria

April 1, 2022

First Posted (Actual)

April 8, 2022

Study Record Updates

Last Update Posted (Actual)

August 12, 2022

Last Update Submitted That Met QC Criteria

August 9, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • A20273336

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Kwit SAS - smoking cessation app

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe